No Image Provided

Eagle Genomics

VC Funding

Series A

DeepTech & AI Healthcare & Biotech Published 1 February 2018

Summary

In a significant market movement during February 2018, Eagle Genomics was the subject of a vc funding. The transaction achieved a gross valuation of £702,576. Leading the round was Science SEED Fund, UK Innovation.

This transaction was brokered by an undisclosed advisor. The deal reflects ongoing market confidence within its sector.

Lead Investor / Acquirer

Science SEED Fund

Lead Investor / Acquirer

UK Innovation

Advising Broker

Undisclosed Firm

Related Deals in DeepTech & AI / Healthcare & Biotech

Series A prioritised

VC Funding

Eagle Genomics

£17,303,308

Nov 2022

VC Funding

Techspert.io

£8,809,481

Oct 2021

VC Funding

Exscientia

£35,000,000

Sept 2021

VC Funding

Eagle Genomics

£6,889,296

Oct 2020

View Company Details

Financials, officers, full deal history

Original Source

This funding round is sourced from the Tech.eu Funding Explorer. View the full record, investors, and citations there.

View on Tech.eu Funding Explorer

Funding data via Tech.eu Funding Explorer, licensed under CC BY 4.0. See our methodology.

AI Insight Lenses

Pro

AI-generated analysis from four professional perspectives. Powered by PE Deals.

Free to all registered users.